This text presents a complete nursing-focused framework for teaching and learning nursing pharmacology, and "places the patient" at the center of all drug and drug administration decisions and considerations. The book presents core drug knowledge using prototypes of different drug classes and emphasizes core patient variables that influence the patient's response to therapy. Features include abundant review questions, concept maps, drug summary tables, drug interaction tables, and critical thinking scenarios that teach students how to apply pharmacology knowledge to patient care.
Online Tutoring powered by Smarthinking—Free online tutoring, powered by Smarthinking, gives students access to expert nursing and allied health science educators whose mission, like yours, is to achieve success. Students can access live tutoring support, critiques of written work, and other valuable tools.
- Updated! Significant updating of drug information and new references
- Additional emphasis placed on safety concerns with drug therapy
- Additional information about pharmacogenetics and pharmacogenomics
- Black Box Warnings: Keeping students focused on key information, for all drugs, not just prototypes
- Color Concept Maps & Drug Summary Tables: Ensuring student understanding and engagement
- Community Based Concerns: Keeping the patient and community at the focus
- Prep U: Adaptive quizzing for students and information for faculty
- Core Patient Variables: Helping students learn what important patient variables to consider
- Focus on Research Boxes: Keeping research at the front of students' minds
- Memory Chips: Pointing out key elements for students to remember
- Physiology Features: Helping students focus on Physiology
- Prototype Approach: Giving students a simpler way to learn and remember drug types
- Questions for Study & Review
- Safety Alerts
- Bundled with "Lippincott's Atlas of Medication Administration" at no extra cost !
Table of Contents
Chap 1: Nursing Management of Drug Therapy (DA) Chap 2: Pharmaceuticals: Development, Safeguards, and Delivery (SV) Chap 3: Drug Administration (DA) II. Core Drug Knowledge Chap 4: Pharmacotherapeutics, Pharmacokinetics, and Pharmacodynamics (DA) Chap 5: Adverse Effects and Drug Interactions (DA) III. Core Patient Variables Chap 6: Life Span: Children (DA) Chap 7: Life Span: Pregnant or Breast-Feeding Women (DA) Chap 8: Life Span: Older Adults (DA) Chap 9: Lifestyle: Substance Abuse (SV) Chap 10: Lifestyle: Nutrition and Complementary Medications (SV) Chap 11: Environment (SV) Chap 12: Culture: Considerations in Drug Therapy (DA) IV. Peripheral Nervous System Drugs Chap 13: Drugs Affecting Adrenergic Function (DA) Chap 14: Drugs Affecting Cholinergic Function (DA) V. Central Nervous System Drug Chap 15: Drugs Relieving Anxiety and Producing Sleep (Barbara Huggins) (old ch.18) Chap 16: Drugs Treating Mood Disorders (Barbara Huggins) (old ch. 19) Chap 17: Drugs Treating Psychotic Disorders and Dementia (Faye Bimbrey) (old ch. 20) Chap 18: Drugs Treating Seizure Disorders (old ch. 21) Chap 19: Drugs Producing Anesthesia and Neuromuscular Blocking (Diane – Andy Benson) (old ch. 15) Chap 20: Drugs Affecting Muscle Spasm and Spasticity (Diane – Andy Benson) (old ch. 16) Chap 21: Drugs Treating Parkinson Disease and Other Movement Disorders (Peggy Jenkins) (old. Ch. 17) Chap 22: Drugs Stimulating the Central Nervous System (Jacqueline Gilreath) VI. Analgesic and Anti-Inflammatory Drugs Chap 23: Drugs Treating Severe Pain (DA) Chap 24: Drugs Treating Mild to Moderate Pain, Fever, Inflammation, and Migraine Headache (SV) Chap 25: Drugs Treating Rheumatoid Arthritis and Gout (SV) VII. Hematopoietic, Cardiovascular and Renal System Drugs Chap 26: Drugs Affecting Blood Pressure (DA) (old ch. 28) Chap 27: Drugs Affecting Urinary Output (DA) (old ch. 27) Chap 28: Drugs Affecting Lipid Levels (DA) (old ch. 26) Chap 29: Drugs Treating Heart Failure (DA) (old ch. 29) Chap 30: Drugs Treating Angina (DA) (old ch. 30) Chap 31: Drugs Affecting Cardiac Rhythm (Nancy Sullivan) Chap 32: Drugs Affecting Coagulation (DA) Chap 33: Drugs Affecting Hematopoiesis (DA) VIII. Respiratory Drugs Chap 34: Drugs Affecting the Upper Respiratory System (SV) (old ch. 48) Chap 35: Drugs Affecting the Lower Respiratory System (SV) (old ch. 49) IX. Gastrointestinal Tract Drugs Chap 36: Drugs Affecting the Upper Gastrointestinal Tract (Janice Hoffman) (old ch. 50) Chap 37: Drugs Affecting Lower Gastrointestinal Tract (Janice Hoffman) (old ch. 51) X. Antimicrobial Drugs Chap 38: Principles of Antimicrobial Therapy (SV) Chap 39: Antibiotics Affecting the Bacterial Cell Wall (SV) Chap 40: Antibiotics Affecting Bacterial Protein Synthesis (SV) Chap 41: Drugs That Are Miscellaneous Antibiotics (SV) Chap 42: Drugs Treating Urinary Tract Infections (SV) Chap 43: Drugs Treating Mycobacterial Infections (SV) Chap 44: Drugs Treating Fungal Infections (SV) Chap 45: Drugs Treating Viral Infections (SV) Chap 46: Drugs Treating HIV and AIDS (G DeJesus) Chap 47: Drugs Treating Parasitic Infections (SV) XI. Endocrine Drugs Chap 48: Drugs Affecting Corticosteroid Levels (Gerry DeJesus) (old ch. 35) Chap 49: Drugs Affecting Blood Glucose Levels (DA) (old ch. 52) Chap 50: Drugs Affecting Pituitary, Thyroid, Parathyroid, and Hypothalamic Function (JVazzano) (old ch. 53) Chap 51: Drugs Affecting Menâ€™s Health and Sexuality (Rane-Szostak ) (old ch. 54) Chap 52: Drugs Affecting Womenâ€™s Health and Sexuality (Woods) (old ch. 55) Chap 53: Drugs Affecting Uterine Motility (Woods) (old ch. 56) XII. Immune System and Cancer Chemotherapy Drugs Chap 54: Drugs that Affects the Immune Response (Shelton) (old ch. 34) Chap 55: Drugs that Affect Specific Targets (Shelton/Olson) (new) Chap 56: Drugs That Are Cell Cycle-Specific (Olson) (old ch. 36) Chap 57: Drugs That Are Cell Cycle-Nonspecific (Olson) (old ch. 37)